RISK OF HOSPITALIZATION OR DEATH DUE TO HEART FAILURE WITH INTENSIVE GLUCOSE-LOWERING THERAPY IN DIABETIC WOMEN: SUBGROUP ANALYSES BY HISTORY OF CARDIOVASCULAR DISEASE IN THE ACCORD TRIAL

Tejas Patel,Bereket Tesfaldet, Eileen Navarro Almario,Gyorgy Csako,George Sopko,Jerome L. Fleg,Ruth Kirby,Charu Gandotra,Helena Sviglin,Keith Burkhart,Karim A. Calis,Jue Chen,Lawton S. Cooper,Frank Pucino,Neha Amin,Henry Chang,Sean Coady, Patrice Desvigne Nickens,Peter G. Kaufmann,Eric S. Leifer,Lijuan Liu,Subha V. Raman,Yves Rosenberg,Ahmed A. K. Hasan

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2017）

引用 0|浏览42

暂无评分

摘要

Background: Patients with type 2 diabetes (T2D) and cardiovascular disease (CVD) often exhibit myocardial insulin resistance, potentially contributing to morbidity and mortality. In a prior secondary analysis of publicly available ACCORD data, we noted increased hospitalization or death due to heart

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要